2019    HDBMB Crossroads in Life Sciences, Lovran, Croatia; Munitic I: Optineurin Dysfunction in Amyotrophic Lateral Sclerosis

2019    23rd Young Neuroscientist Meeting, Trieste, Italy; Prtenjača N: Elucidating the Role of Optineurin in Inflammation and Autophagy

2019    Mind & Brain, Pula, Croatia; Munitic I: Optineurin Dysfunction in Neurodegeneration

2019    International Conference on Neurological Disorders and Neurorestoration, Dubrovnik, Croatia; Munitic I: Immunity in Amyotrophic Lateral Sclerosis

2019    4th Croatian Neuroimmunological Congress with international participation, Opatija, Croatia; Munitic I: Neuroimmunology of ALS

2019    Diagnostics and Therapy of Motor Neuron Disorders, Zagreb, Croatia; Munitic I: Neurodegeneration and Immunity

2018    Annual Meeting of the Croatian Immunological Society, Zadar, Croatia; Markovinovic A: Loss of optineurin leads to disbalance in pro- and anti-inflammatory factors regulated by IFN-β

2018    XXVII AINI Congress 2018, Trieste, Italy; Markovinovic A: Loss of optineurin leads to disbalance in pro- and anti-inflammatory factors regulated by IFN-β

2018     Dilemmas in neurology, Poreč, Croatia; Munitic I: Immunology in ALS: historic overview and future perspectives   

2018     Faculty for Humanities, and Social Sciences, University of Rijeka, Croatia; Munitic I: Vaccination: scientific foundations    

2018    Annual meeting of Croatian Laboratory Animal Science Association (CroLASA), Zagreb, Croatia; Munitic I: Developing new mouse models for studying amyotrophic lateral sclerosis

2017    13th Symposium of the André-Delambre Foundation, Montreal, Canada; Munitic I: Characterization of the role of optineurin in neurodegeneration, .  

2017    Laval   University, CERVO Brain, Research Centre Quebec City, Canada; Munitic I: Elucidating the role of optineurin in amyotrophic lateral sclerosis   

2017    Croatian National Academy of Sciences and Arts 1st Rijeka Forum on Neurodegenerative Diseases,

Rijeka, Croatia; Munitic I: Animal Models of Amyotrophic Lateral Sclerosis,    

2017    Croatian Science Foundation installation grant presentation, Medical Faculty, University of Rijeka, Croatia; Munitic I: Elucidating the role of optineurin in neuroprotection,   

2017     Regional meeting of clinicians and basic scientists that work on ALS, Ljubljana, Slovenia; Munitic I: Molecular characterization of mouse optineurin insufficiency models,   

2016    20th Young Neuroscientists Meeting, Rijeka, Croatia; Markovinovic A: An optineurin insufficiency model as a potential tool for elucidating the pathogenesis of amyotrophic lateral sclerosis

2016    Faculty for Humanities, and Social Sciences, University of Rijeka, Croatia; Munitic I: Experiences and challenges of young researchers in biomedicine   

2016    European Network for the Cure of ALS (ENCALS) meeting, Milano, Italy: Munitic I: An Optineurin insufficiency model of ALS.

2015      4th European Congress of Immunology, Vienna, Austria; Munitic I: Endogenous Glucocorticoids Suppress Dendritic Cell-derived IL-12 and Prevent Death in LPS-induced sepsis,

2014    10th Symposium of the André-Delambre Foundation, Montreal, Canada; Munitic I: A Mouse Model of Optineurin Insufficiency  

2014    Symposium of the Croatian National Academy of Sciences, “New discoveries in immunology and hematology”, Rijeka, Croatia; Munitic I: New functions of dendritic cells: novel DC with T cell attributes (TDC) and DC regulation by glucocorticoids during sepsis.